NRIX
Nurix Therapeutics·NASDAQ
--
--(--)
--
--(--)
NRIX fundamentals
Nurix Therapeutics (NRIX) released its earnings on Jul 9, 2025: revenue was 44.06M (YoY +264.34%), beat estimates; EPS was -0.52 (YoY +26.76%), beat estimates.
Revenue / YoY
44.06M
+264.34%
EPS / YoY
-0.52
+26.76%
Report date
Jul 9, 2025
Earnings Call
4:00 PM on Jul 7, 2025
Meeting link.EPS
Actual | -0.59 | -0.51 | -0.63 | -0.6 | -0.65 | -0.85 | -0.95 | -1.01 | -0.9 | -0.87 | -0.75 | -0.45 | -0.68 | -0.77 | -0.76 | -0.71 | -0.67 | -0.75 | -0.67 | -0.52 |
Forecast | -0.4125 | -0.534 | -0.4525 | -0.535 | -0.6214 | -0.6825 | -0.8757 | -0.9713 | -0.9479 | -0.783 | -0.8673 | -0.5673 | -0.8385 | -0.4964 | -0.7756 | -0.6348 | -0.6877 | -0.6861 | -0.7619 | -0.7187 |
Surprise | -43.03% | +4.49% | -39.23% | -12.15% | -4.60% | -24.54% | -8.48% | -3.98% | +5.05% | -11.11% | +13.52% | +20.68% | +18.90% | -55.12% | +2.01% | -11.85% | +2.57% | -9.31% | +12.06% | +27.65% |
Revenue
Actual | 4.08M | 6.69M | 5.01M | 7.09M | 10.25M | 7.40M | 9.62M | 11.43M | 10.79M | 6.78M | 12.69M | 30.68M | 18.47M | 15.16M | 16.59M | 12.09M | 12.59M | 13.28M | 18.45M | 44.06M |
Forecast | 6.35M | 3.94M | 8.68M | 8.23M | 8.54M | 13.19M | 9.27M | 10.51M | 12.07M | 17.17M | 10.96M | 26.24M | 11.94M | 34.14M | 17.13M | 22.11M | 11.98M | 12.73M | 13.00M | 17.55M |
Surprise | -35.67% | +69.56% | -42.24% | -13.80% | +19.99% | -43.95% | +3.75% | +8.82% | -10.61% | -60.50% | +15.76% | +16.92% | +54.71% | -55.60% | -3.20% | -45.30% | +5.09% | +4.34% | +41.95% | +151.08% |
Earnings Call
You can ask Aime
What does Nurix Therapeutics do and what are its main business segments?What were the key takeaways from Nurix Therapeutics’s earnings call?What is Nurix Therapeutics's latest dividend and current dividend yield?Did Nurix Therapeutics beat or miss consensus estimates last quarter?What is the revenue and EPS growth rate for Nurix Therapeutics year over year?What were the key takeaways from Nurix Therapeutics's earnings call?What factors drove the changes in Nurix Therapeutics's revenue and profit?What is the market's earnings forecast for Nurix Therapeutics next quarter?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
